PROBIOTIX HEALTH LS-05
Research PROBIOTIX HEALTH LS-05 (X90) on Bullrun: market cap EUR 14.86M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerX90
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 14.86M
- Financial periodFY2024
- RevenueGBP 1.88M
- Revenue growth12.6%
- Net income-GBP 847.00K
- Free cash flow-GBP 1.07M
- Gross margin52.9%
Valuation Snapshot
latest market cap is EUR 14.86M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | GBP 1.88M | -GBP 847.00K | -GBP 1.07M | 52.9% | -0.01 | GBP 1.65M | n/a | GBP 1.92M |
| FY2023 | GBP 1.67M | -GBP 747.00K | -GBP 238.00K | 52.1% | -0.01 | GBP 1.50M | n/a | GBP 1.53M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-09 | EUR 14.86M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
Related stock research
Other Healthcare stocks
IMMUPHARMA PLC LS-01 (25I)
4BASEBIO UK SOCIETAS (4BB)
SKINBIO THERAP LS-01 (5KW)
ARECOR THERAPEUTICS -01 (6UI)
4BASEBIO PLC EO 1 (88Q)
EVGEN PHARMA PLC LS-0025 (8EV)
Aptamer Group PLC (APTA)
Autolus Therapeutics plc (AUTL)
Avacta Group PLC (AVCT)
Bicycle Therapeutics Plc (BCYC)
Biodexa Pharmaceuticals Plc (BDRX)
Bioventix (BVXP)
Frequently asked questions
What is PROBIOTIX HEALTH LS-05's market cap?
PROBIOTIX HEALTH LS-05's market capitalization is EUR 14.86M.